145 related articles for article (PubMed ID: 8400066)
1. Reversible renal failure in the primary antiphospholipid syndrome--a report of two cases.
Sokunbi DO; Miller F; Wadhwa NK; Nord EP
J Am Soc Nephrol; 1993 Jul; 4(1):28-35. PubMed ID: 8400066
[TBL] [Abstract][Full Text] [Related]
2. Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency.
Peddi VR; Kant KS
J Am Soc Nephrol; 1995 May; 5(11):1882-7. PubMed ID: 7620085
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibody syndrome and renal disease.
Joseph RE; Radhakrishnan J; Appel GB
Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):175-81. PubMed ID: 11224691
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic renal and adrenal manifestations of primary antiphospholipid syndrome.
Bazzi L; Taher AT; Musallam KM; Saleh Z; Masrouha KZ; Uthman I
Rheumatol Int; 2010 May; 30(7):993-4. PubMed ID: 19701636
[No Abstract] [Full Text] [Related]
5. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
Fakhouri F; Noël LH; Zuber J; Beaufils H; Martinez F; Lebon P; Papo T; Chauveau D; Bletry O; Grünfeld JP; Piette JC; Lesavre P
Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
7. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
[TBL] [Abstract][Full Text] [Related]
8. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis.
Cacoub P; Wechsler B; Piette JC; Beaufils H; Herreman G; Bletry O; Godeau P
Clin Exp Rheumatol; 1993; 11(5):479-85. PubMed ID: 8275582
[TBL] [Abstract][Full Text] [Related]
9. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
[TBL] [Abstract][Full Text] [Related]
10. Calciphylaxis in catastrophic antiphospholipid antibody syndrome.
Shah S; Larson A; Datta Y
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):467-8. PubMed ID: 25688465
[TBL] [Abstract][Full Text] [Related]
11. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A
Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230
[TBL] [Abstract][Full Text] [Related]
12. [Catastrophic antiphospholipid syndrome].
Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
[TBL] [Abstract][Full Text] [Related]
13. Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.
Moss KE; Isenberg DA
Rheumatology (Oxford); 2001 Aug; 40(8):863-7. PubMed ID: 11511754
[TBL] [Abstract][Full Text] [Related]
14. Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.
Diószegi Á; Tarr T; Nagy-Vincze M; Nánásy-Vass M; Veisz R; Bidiga L; Dezső B; Balla J; Szodoray P; Szekanecz Z; Soltész P
Lupus; 2018 Aug; 27(9):1552-1558. PubMed ID: 29635999
[TBL] [Abstract][Full Text] [Related]
15. Renal involvement in antiphospholipid syndrome.
de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
17. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
18. Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis.
Sinniah R; Gan HC; Yoon KH
Am J Nephrol; 2001; 21(2):134-40. PubMed ID: 11359021
[TBL] [Abstract][Full Text] [Related]
19. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
Tektonidou MG; Sotsiou F; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
